U.S. Department of Health and Human Services — National Institutes of Health

Human ABL kinase in complex with nilotinib

Autogenerated by

for

pleasureoffiguring

Created on Tue, 2016-08-16 21:23, last updated on Tue, 2016-08-16 21:23

I Printed This

Remix It

Vertical Tabs

General Information

This Model was autogenerated from the "Quick Submit" tool.

Model ID

3DPX-003595

Category

Proteins, Macromolecules and Viruses

Keyword(s)

nilotinib, amn107, KINASE, Abl, ATP-binding, CELL ADHESION, cytoskeleton, Lipoprotein, Magnesium, manganese

Protein Data Bank ID

Model Details

Experimental Method

X-RAY DIFFRACTION

Associated Species

Spodoptera frugiperda

Resolution

2.20

Oligomeric Details

monomeric

R-Factor

0.19965

Scattering Type

x-ray

Attribution

PubMed ID

Digital Object Identifier (DOI)

10.1016/j.ccr.2005.01.007

Citation Title

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Citation Year

2005

STL/VRML Files

PDB-3CS9-ribbon-secondary.wrl

PDB-3CS9-ribbon-rainbow.wrl

PDB-3CS9-ribbon-bychain.wrl

PDB-3CS9-ribbon.stl

PDB-3CS9-ribbon-thick.stl

PDB-3CS9-surf-bychain.wrl

PDB-3CS9-surf-hydropathy.wrl

PDB-3CS9-surf-coulombic.wrl

PDB-3CS9-surf.stl

X3D Files

PDB-3CS9-ribbon-secondary.x3d

PDB-3CS9-ribbon-rainbow.x3d

PDB-3CS9-ribbon-bychain.x3d

PDB-3CS9-ribbon.x3d

PDB-3CS9-ribbon-thick.x3d

PDB-3CS9-surf-bychain.x3d

PDB-3CS9-surf-hydropathy.x3d

PDB-3CS9-surf-coulombic.x3d

PDB-3CS9-surf.x3d

Blender Files

PDB-3CS9-ribbon-secondary.blend

PDB-3CS9-ribbon-rainbow.blend

PDB-3CS9-ribbon-bychain.blend

PDB-3CS9-ribbon.blend

PDB-3CS9-ribbon-thick.blend

PDB-3CS9-surf-bychain.blend

PDB-3CS9-surf-hydropathy.blend

PDB-3CS9-surf-coulombic.blend

PDB-3CS9-surf.blend

PDB-3CS9-ribbon-secondary.x3d

PDB-3CS9-ribbon-rainbow.x3d

PDB-3CS9-ribbon-bychain.x3d

PDB-3CS9-ribbon.x3d

PDB-3CS9-ribbon-thick.x3d

PDB-3CS9-surf-bychain.x3d

PDB-3CS9-surf-hydropathy.x3d

PDB-3CS9-surf-coulombic.x3d

PDB-3CS9-surf.x3d

QR Code for https://3dprint.nih.gov/discover/3dpx-003595

Rating

Licensing

Comments

0